Tag: information

AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced the pricing of its previously announced a public offering of 10,879,376 shares of its common stock at a public offering price per share of $4.00 and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 7,870,624 shares of its common stock at a public offering price of $3.9999 per pre-funded warrant. The pre-funded warrants have an exercise price of $0.0001 per share and are exercisable immediately. The aggregate gross proceeds to Shattuck from the offering are expected to be approximately $75 million before deducting underwriting discounts and commissions and other offering expenses payable by Shattuck, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on June 11, 2026, subject to the satisfaction of customary closing conditions. In addition, Shattuck has granted the underwriters an option for a period of 30 days to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions.

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 10, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the...

High Arctic Announces Management Changes

CAMPBELL, Calif., June 8, 2026 /PRNewswire/ -- After a decade of consumers being overwhelmed with biometric data but lacking supportive ways to act on it,...

Dual initiatives advance Group strategy by tripling parcel processing capacity to lower cost-to-serve and enhancing public convenienceSINGAPORE, June 10, 2026 /PRNewswire/ -- Singapore Post...

GeneDx (WGS) Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

SHANGHAI, June 10, 2026 /PRNewswire/ -- Carestream announces the availability of its new generation of Cesium Iodide (CsI), glass-free X-ray Detector in markets all...

Minami Maeda appointed as CEO to drive faster, more focused execution toward U.S. commercial launchMickey Mikitani will continue to provide strategic direction and remains...

Peer-nominated award honors leaders who exemplify community impact and a commitment to changing the odds for kids across California.SANTA ANA, Calif., June 9, 2026...

SHENZHEN, China, June 10, 2026 (GLOBE NEWSWIRE) -- A showcase of premium agricultural products from Heilongjiang Province drew enthusiastic responses from faculty and students at Harbin Institute of Technology, Shenzhen on Tuesday, bringing the flavors of China's northeastern "black soil" region to the country's southern tech hub.

SEATTLE, June 9, 2026 /PRNewswire/ -- Two hundred and fifty nurse practitioners and physician assistants working across multiple clinic locations at Fred Hutchinson Cancer...